Professional Documents
Culture Documents
A* Extension 3.6: Eukaryotic flagella and the structure of the sperm tail
Cilia and agella are organelles that project from the surface of certain cells. Cilia occur in large numbers on certain large cells, such as the ciliated lining (epithelium) of the air tubes serving the lungs (bronchi). Flagella occur singly, typically on small, motile cells for example, motile sex cells such as a sperm (see illustration on the next page). Sometimes they occur in pairs. Structurally, cilia and agella are almost identical, and both can move. Their movement may cause a motile cell to move (e.g. sperm), or may cause the movement of uid across the cell surface (e.g. mucus along the bronchial lining). In a unicellular animal such as the protozoan Paramecium, cilia generate a special feeding current. Internally, cilia and agella consist of nine pairs of microtubules arranged in an outer ring, surrounded by a single central pair, all enclosed in an extension of the plasma membrane. These microtubules are connected to a basal body, just below the body surface. All along the microtubules are side-arms, also made of protein. These side structures contain enzymes that release energy from ATP, the energy currency of cells, and they appear to work in a similar way to the sliding lament mechanism between actin and myosin in our muscle myobrils.
Protein side-arms to the microtubules react with ATP and bring about sliding movements of the microtubules that cause the movements of the cilium or flagellum.
flagellum of sperm
Now look at the structure of the sperm (Figure 3.24, page 120 in the students book). The tail region has the basic structure of a agellum. Behind the head, the midpiece is packed with mitochondria. This is where the ATP is generated that is needed to fuel the swimming movements of the tail.
blood vessels
10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 time (days)
THE VOICE OF THE GENOME A* EXTENSIONS vessels. They have also been transformed into brain, heart and muscle cells of mice, but only in in vitro experiments, so far. The next step is for the researchers to repeat these processes in humans. If this can be done, then an ethically acceptable source of stem cells may be available for the treatment of diseases such as Parkinsons, Alzheimers, strokes and diabetes, perhaps. This work was rst reported in Nature in September, 2007.